Newsroom

PARIS--(BUSINESS WIRE)--Regulatory News: Vivendi (Paris:VIV): Le présent descriptif est établi en application des dispositions des articles 241-1 et 241-2 du Règlement général de l’Autorité des marchés financiers. 1. Date de l’Assemblée générale ayant autorisé le programme de rachat d’actions et de mise en œuvre. L’autorisation d’achat par la société de ses propres actions a été donnée par l’Assemblée générale mixte du 28 avril 2025 (dix-neuvième résolution). Elle est mise en œuvre sur délégati...

LUXEMBURGO--(BUSINESS WIRE)--Omnes ha anunciado hoy una colaboración estratégica con Apex Group, un proveedor líder internacional de servicios financieros con más de 3,5 billones de dólares en activos gestionados, para tokenizar su producto estrella, el Omnes Mining Note «OMN». El OMN es un título estructurado de grado institucional respaldado por el hashrate de bitcoin, que se emitirá y gestionará en Base Chain, la capa 2 de Ethereum en fase de desarrollo en Coinbase, aprovechando Apex Digital...

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or “the Company”) today announced that it and certain of its subsidiaries have entered into two definitive agreements to sell (i) all of the ownership interests of its subsidiaries engaged in the business of cultivating, producing, manufacturing, distributing and selling cannabis in the State of Ohio to Holistic Industries Inc., a Delaware corporation (“Holistic”); and...

PECHINO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), un’azienda biotecnologica globale che dà impulso alla ricerca e sviluppo di farmaci innovativi basati su anticorpi impiegando tecnologie all’avanguardia, oggi ha annunciato una collaborazione strategica con Moonlight Bio, Inc., società biotecnologica con sede a Seattle, pioniera nelle terapie cellulari all’avanguardia. Questa collaborazione mira a sviluppare terapie cellulari all’ava...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Giles Foodservice Equipment is reducing its reliance on delivered liquid nitrogen by generating it on-site, a move projected to save the company $500,000 over the next decade. Powered by an ELGi air compressor and implemented with Mobile Mechanical Services, the new system supports continuous-duty manufacturing and future growth. Using compressed air, the system separates nitrogen from ambient air and delivers it directly to Giles’ laser cutting operations. By...

WOODSTOCK, Ga.--(BUSINESS WIRE)--Prestige Medical Group, a physician-led healthcare organization serving North Georgia for more than 20 years, announced plans to open a new medical office in Woodstock, Georgia. The new location, opened on March 24, 2026, located at 102 Springfield Center Drive, Woodstock, GA 30188. The Woodstock office represents a strategic expansion of Prestige Medical Group’s footprint, designed to improve access and convenience for patients and families in Cherokee County a...

NEW YORK--(BUSINESS WIRE)--KBRA releases research that explores the potential credit implications of the conflict involving Iran for the airline sector, including both near-term effects and the potential impact of a prolonged disruption. The conflict represents a multichannel shock for airlines, impairing flows through the Strait of Hormuz, disrupting regional refining activity, increasing shipping and insurance costs, and constraining Middle East airspace. The most immediate credit transmissio...

LIESTAL, Svizzera--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, “Curatis”) annuncia ricavi aziendali pari a 10,8 milioni di franchi (+57%) per il 2025. Curatis AG ha riportato un aumento organico del fatturato nella sua attività di distribuzione pari al 13%, da 9,5 milioni di franchi a 10,8 milioni di franchi. Il risultato netto è migliorato da una perdita di 4,3 milioni di franchi nel 2024 a una perdita di 1,4 milioni di franchi nel 2025. Ulteriori importanti dichiarazioni Nel settembre 2025...

LIESTAL, Zwitserland--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, “Curatis”) rapporteert een bedrijfsomzet van CHF 10,8m (+57%) voor 2025. Curatis AG kende een organische stijging van de verkoop in haar distributieactiviteiten met 13%, van CHF 9,5m naar CHF 10,8m. Het nettoresultaat verbeterde van een verlies van CHF 4,3m in 2024 naar een verlies van CHF 1,4m in 2025. Andere belangrijke verklaringen In september 2025 werd ons ontwikkelingsplan voor corticorelin gevalideerd tijdens een vergad...

LAS VEGAS--(BUSINESS WIRE)--Roseman Bioventures aims to accelerate the commercialization of life science innovations and expand the Nevada biotech ecosystem....